NCT01150370

Brief Summary

The protocol, approved by the Rwanda National Ethical Committee, was issued to assess the safety and efficacy of the circumcision device for applying it to the national scale up of adult male circumcision in Rwanda

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

June 23, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 25, 2010

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

January 11, 2011

Status Verified

December 1, 2010

Enrollment Period

6 months

First QC Date

June 23, 2010

Last Update Submit

January 10, 2011

Conditions

Keywords

male circumcisionHIVRwandaHIV Seronegativity

Outcome Measures

Primary Outcomes (1)

  • The efficacy and safety of The PrePex System for adult male circumcision in Rwanda

    Outcome measures will include: Number of Participants with Adverse Events as a Measure of Safety, Pain as measured by Visual Analogue Scale (VAS), Wound healing rate.

    4 week post-procedure follow up appointment and examination

Secondary Outcomes (4)

  • Operational scalability to mass scale up program

    four week post-procedure follow up appointment and examination

  • satisfaction & acceptability of patients

    4 weeks follow up

  • Guidelines for utility in scale up mass circumcision program

    4 weeks follow up

  • compliance with post procedure instructions

    4 weeks follow up

Study Arms (1)

Males undergoing circumcision

EXPERIMENTAL
Device: The PrePex a novel device for adult male circumcision

Interventions

The PrePex System was designed to enable safe, effective, painless and bloodless male circumcision programs. The PrePex System includes a simple, disposable device that is easy to use and can be deployed by minimally trained healthcare professionals, without the need for sterile, hospital settings.

Males undergoing circumcision

Eligibility Criteria

Age18 Years - 54 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male of ages 18 - 54 years
  • Subject wants to be circumcised
  • Uncircumcised
  • HIV sero-negative Agrees to undergo measurements of width of the penis at different areas in flaccid status
  • Able to understand the study procedures and requirements
  • Agrees to abstain sexual intercourse and to keep caution not directly rub the cut area if masturbating, until the end of the follow-up that may take up to 6 weeks
  • Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study

You may not qualify if:

  • Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision
  • HIV sero-positive
  • Subject with the following diseases: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias
  • Diabetes mellitus
  • Subject who have an abnormal penile anatomy or any penile diseases
  • Subject that to the opinion of the investigator is not a good candidate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kanombe Military Hospital

Kigali, Kigali, 3377, Rwanda

Location

Related Links

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Dr. Jean Paul Bitega, M.D.

    Kanombe Military Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

June 23, 2010

First Posted

June 25, 2010

Study Start

June 1, 2010

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

January 11, 2011

Record last verified: 2010-12

Locations